2025-524899-40-00RecruitingPhase 1
A First-in-Human Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of MR-L45 in Healthy Adults
Source: EU CTIS (euclinicaltrials.eu) · Last updated 20 Aug 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- First submitted
- 20 Feb 2026
- Start date
- 3 Jul 2026
- Lead sponsor
- Mironid Limited
- EU CT number
- 2025-524899-40-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 72
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pharmaceutical Research Associates Group B.V. | Groningen | Netherlands | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.